The most successful players — both old and new — are those focusing on operational risk control rather than assay novelty.

Ubiquitination is a crucial post-translational modification process where the small protein ubiquitin is attached to target proteins, marking them for degradation or altering their function. This ...

NIMHANS researchers propose a new model for early protein deposits in Parkinson’s, offering insights for future drug ...

Itaconate, an endogenous mitochondrial metabolite produced by the enzyme aconitate decarboxylase 1 (ACOD1), has emerged as a central regulator of ...

Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering single-molecule proteome analysis, today announced the launch of an Early Access Program for ...

Shanghai has laid out a 20-step plan to advance its novel food sector over the next five years, with new products and regulatory approvals among the chief goals. Shanghai wants to spearhead China’s ...

On December 29, 2025, Quantum-Si posted an updated corporate presentation for investors on its website, outlining its strategy to capitalize on what it sees as a more than $75 billion and rapidly ...

The Warburg effect describes how cancer cells switch from oxidative phosphorylation to glycolysis even in oxygen-rich conditions, producing massive amounts of lactate that accumulate in the tumor ...

Researchers at Baylor College of Medicine have developed an artificial intelligence (AI) model that reveals how protein modifications link genetic mutations to disease. The method, called DeepMVP and ...

A molecular model showing three of the main epigenetic modifications of DNA (orange) and histones (dark blue) [JUAN GAERTNER/Science Photo Library/Getty Images] Post-translational modifications (PTMs) ...